Global Rapid Tests Market to Reach $49 Billion by 2030
The global market for Rapid Tests estimated at US$30.5 Billion in the year 2022, is projected to reach a revised size of US$49 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2022-2030. PCR-Based, one of the segments analyzed in the report, is projected to record a 6.9% CAGR and reach US$20 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Chromatography-Based segment is readjusted to a revised 6% CAGR for the next 8-year period.
The U.S. Market is Estimated at $8.3 Billion, While China is Forecast to Grow at 10.1% CAGR
The Rapid Tests market in the U.S. is estimated at US$8.3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$11 Billion by the year 2030 trailing a CAGR of 10.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.1% and 6.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$6.7 Billion by the year 2030.Select Competitors (Total 38 Featured) -
- ALS Ltd.
- AsureQuality Ltd.
- Bureau Veritas SA
- Eurofins Scientific SE
- Genetic ID NA, Inc.
- Intertek Group PLC
- Mérieux NutriSciences Corporation
- Microbac Laboratories, Inc.
- Omic USA Inc.
- Romer Labs, Inc.
- SGS SA
- Tuv Sud AG
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ALS Ltd.
- AsureQuality Ltd.
- Bureau Veritas SA
- Eurofins Scientific SE
- Genetic ID NA, Inc.
- Intertek Group PLC
- Mérieux NutriSciences Corporation
- Microbac Laboratories, Inc.
- Omic USA Inc.
- Romer Labs, Inc.
- SGS SA
- Tuv Sud AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 171 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 30.5 Billion |
| Forecasted Market Value ( USD | $ 49 Billion |
| Compound Annual Growth Rate | 6.1% |
| Regions Covered | Global |
![In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030 - Product Image](http://www.researchandmarkets.com/product_images/12002/12002788_60px_jpg/invitro_diagnostics_market.jpg)
